847O Sequential chemoradiotherapy versus induction chemotherapy plus concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A multicentre, open-label, non-inferiority, randomised, phase III trial

Chenxia Hu(Huazhong University of Science and Technology), Xiayun He(Fudan University Shanghai Cancer Center), J. Li, Xuanyi Chen(Zhejiang Cancer Hospital), Congying Xie(Wenzhou Medical University), Tingting Xu(Tongji University), Chao Shen(Huashan Hospital), Sen Lin(Fujian Medical University), Xiangdong Zhou(Army Medical University), Fei Xue(Shanghai Normal University), Wei Li(Bethune International Peace Hospital), Fan Zhang(Southwest Medical University), Xiaomin Lu(Nantong University), Dan Ou(Fudan University Shanghai Cancer Center), Xiaomin Ou(Fudan University Shanghai Cancer Center), Hao Ying(Shanghai Institute of Nutrition and Health), Chengrun Du(Fudan University Shanghai Cancer Center)
Annals of Oncology
September 1, 2024
10.1016/j.annonc.2024.08.908
Cited by 1

Related Papers

Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2017|1.2k
Ancient genomes from northern China suggest links between subsistence changes and human migration
|Nature Communications|2020|342
Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
|JAMA|2015|285
Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment
|Engineering|2020|252
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer
|Genome Research|2012|246